Estimating a minimally important difference in pulmonary arterial hypertension following treatment with sildenafil.

@article{Gilbert2009EstimatingAM,
  title={Estimating a minimally important difference in pulmonary arterial hypertension following treatment with sildenafil.},
  author={Claire Gilbert and Martin C J Brown and Joseph C. Cappelleri and Martin O. Carlsson and Stephen P McKenna},
  journal={Chest},
  year={2009},
  volume={135 1},
  pages={137-142}
}
BACKGROUND No guidelines exist to help physicians determine whether functional and health-related quality of life (HRQoL) changes observed following treatment of patients with pulmonary arterial hypertension (PAH) represent important benefits. These analyses were undertaken to help define a minimally important difference (MID) in exercise capacity, measured by the 6-min walk distance (6MWD), and HRQoL, measured by the Short Form-36 (SF-36) questionnaire in patients with PAH. PATIENTS AND… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Using the standard error of measurement to Identify important changes on CHEST/135/1

  • KW Wyrwich, WM Tierney, FD. Wolinsky
  • 2009

1M, [enktnson C. Distribution-based criteria for change in health-related quality of life in Parkinson's disease

  • R Fitzpatrick, Norquist
  • I Clin Epidemiol
  • 2004

Similar Papers

Loading similar papers…